Untitled-2 Untitled-2 Untitled-2
Healthcare
For Life
1315 Capital invests in exceptional healthcare teams and companies

1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage medical technology, healthcare service, and specialty pharmaceutical companies. We target markets where high-quality management teams can rapidly scale platform companies into large and important businesses that positively impact patients, physicians, and the broader healthcare system.

Investment
Leadership

The 1315 Capital investment team combines financial and business development expertise with deep industry knowledge to support the growth of our portfolio companies.

Learn More

OPERATING
TEAMS

1315 Capital employs a unique Operating Team model to navigate diligence, drive decisions, and achieve premium exits.

Learn More

Tangible
ENGAGEMENT

1315 Capital has a deep network that it leverages for management talent, advisors, deal sourcing, diligence, and boards roles.

Learn More

News & Events
NeoGenomics Completes Acquisition of Genoptix, Inc.
December 10, 2018
Encore Dermatology, Inc. Announces Phase 2 Safety Data Demonstrating Lower Systemic Drug Exposure With Impoyz™ (clobetasol propionate) Cream, 0.025% Compared to Temovate® (clobetasol propionate) Cream, 0.05%
November 27, 2018
Innovative Health Receives FDA Clearances to Reprocess St. Jude Medical’s Advisor™ FL, Two Medtronic Diagnostic Catheters and Biosense Webster’s DECANAV®.
November 26, 2018
Portfolio

Cost-containment service company providing hospitals with turn key liquidation of used equipment.

Special needs equipment and supply company that serves the pediatric and adult special needs population.

Cosmeceutical company providing natural, mineral-based approach to skin protection and skin health.

Dermatology company committed to delivering innovative prescription therapies and medical devices to dermatologists.

Oncology diagnostics company that provides oncologists and pathologists with comprehensive testing solutions in hematology and solid tumor molecular profiling.

Cost-containment service company focused on reprocessing single-use medical devices.

Specialty pharmaceutical company focused on nutraceutical and women’s health products.

Medical device company focused on the orthopedic oncology market.

Medical technology company providing advanced wound care products to patients with chronic wounds.